Chi-An Chen Selected Research

1,2-distearoyllecithin

1/2009	Phase II trial of carboplatin and distearoylphosphatidylcholine pegylated liposomal doxorubicin (Lipo-Dox) in recurrent platinum-sensitive ovarian cancer following front-line therapy with paclitaxel and platinum.
6/2006	Pegylated liposomal doxorubicin (Lipo-Dox) for platinum-resistant or refractory epithelial ovarian carcinoma: a Taiwanese gynecologic oncology group study with long-term follow-up.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chi-An Chen Research Topics

Disease

47	Neoplasms (Cancer) 01/2021 - 03/2002
16	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 03/2004
15	Carcinoma (Carcinomatosis) 01/2019 - 03/2002
13	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 03/2003
10	Ascites 01/2017 - 03/2004
8	Ovarian Epithelial Carcinoma 10/2021 - 03/2004
6	Carcinogenesis 06/2015 - 03/2003
5	Endometrial Neoplasms (Endometrial Cancer) 03/2021 - 06/2009
4	Neoplasm Metastasis (Metastasis) 12/2015 - 01/2005
4	Infections 03/2008 - 05/2005
2	Malignant Mesothelioma 01/2018 - 07/2007
2	Lymphatic Metastasis 06/2015 - 03/2002
2	Adenocarcinoma 02/2011 - 12/2006
2	beta-Thalassemia (Cooley's Anemia) 08/2008 - 10/2003
1	AIDS-Related Complex (ARC) 03/2021
1	Disease Progression 01/2021
1	Proteinuria 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Asthma (Bronchial Asthma) 01/2019
1	Ileus 02/2018
1	Polyps 01/2018
1	Drug Hypersensitivity (Drug Allergy) 01/2017
1	Hypersensitivity (Allergy) 01/2017
1	Endometrioid Carcinoma 01/2015
1	Clear Cell Adenocarcinoma 01/2015
1	Aromatic amino acid decarboxylase deficiency 09/2014
1	Peritoneal Neoplasms 06/2014

Drug/Important Bio-Agent (IBA)

13	AntigensIBA 09/2019 - 05/2005
10	Proteins (Proteins, Gene)FDA Link 09/2019 - 03/2004
10	DNA VaccinesIBA 05/2019 - 05/2005
8	VaccinesIBA 09/2019 - 07/2004
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2006
7	Paclitaxel (Taxol)FDA LinkGeneric 11/2019 - 01/2009
5	MesothelinIBA 01/2018 - 11/2006
5	Neoplasm Antigens (Tumor Antigens)IBA 01/2018 - 05/2005
5	Biological ProductsIBA 12/2015 - 03/2004
5	Interleukin-6 (Interleukin 6)IBA 01/2012 - 03/2003
4	A-Form DNA (A-DNA)IBA 10/2021 - 05/2005
4	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 05/2005
4	NF-kappa B (NF-kB)IBA 12/2014 - 03/2004
3	PlatinumIBA 11/2019 - 06/2006
3	Messenger RNA (mRNA)IBA 01/2019 - 03/2004
3	Poly I-CIBA 01/2018 - 07/2004
3	CytokinesIBA 10/2013 - 01/2005
3	CalreticulinIBA 01/2006 - 05/2005
2	Peptides (Polypeptides)IBA 07/2019 - 06/2005
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 07/2019 - 06/2005
2	Cisplatin (Platino)FDA LinkGeneric 02/2018 - 05/2008
2	LigandsIBA 01/2018 - 01/2016
2	Toll-Like Receptor 3IBA 01/2018 - 01/2016
2	Carboplatin (JM8)FDA LinkGeneric 01/2017 - 01/2009
2	Morphine (MS Contin)FDA LinkGeneric 01/2016 - 01/2006
2	ArsenicIBA 12/2014 - 01/2005
2	Arsenic Trioxide (Trisenox)FDA Link 12/2014 - 01/2005
2	Estrogens (Estrogen)FDA Link 01/2014 - 08/2011
2	Cancer VaccinesIBA 01/2013 - 06/2010
2	Interleukin-10 (Interleukin 10)IBA 09/2012 - 01/2012
2	1,2-distearoyllecithinIBA 01/2009 - 06/2006
2	liposomal doxorubicin (Doxil)FDA Link 01/2009 - 06/2006
2	beta-Globins (beta Globin)IBA 08/2008 - 10/2003
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2007 - 03/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2005 - 03/2003
1	Connective Tissue Growth FactorIBA 05/2019
1	MTOR InhibitorsIBA 05/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Bevacizumab (Avastin)FDA Link 01/2019
1	CateninsIBA 01/2019
1	Chitinase-3-Like Protein 1IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Ifosfamide FDA LinkGeneric 02/2018
1	Toll-Like Receptor AgonistsIBA 01/2016
1	Tetracycline (Achromycin)FDA LinkGeneric 12/2015
1	Histone MethyltransferasesIBA 12/2015
1	MethyltransferasesIBA 12/2015
1	Cadherins (E-Cadherin)IBA 12/2015
1	Interleukin-17 (Interleukin 17)IBA 10/2015
1	interleukin-21 (interleukin 21)IBA 10/2015
1	Immunologic Factors (Immunomodulators)IBA 10/2015
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 06/2015
1	Insulin-Like PeptidesIBA 04/2015
1	Insulin-Like Growth Factor I (IGF-1)IBA 04/2015
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 04/2015
1	Telomerase (Telomerase Reverse Transcriptase)IBA 02/2015
1	Prostaglandins DIBA 09/2014

Therapy/Procedure

13	Therapeutics 11/2019 - 07/2004
13	Immunotherapy 09/2019 - 07/2004
12	Drug Therapy (Chemotherapy) 11/2019 - 03/2002
6	Hysterectomy 01/2019 - 03/2002
4	Radiotherapy 03/2021 - 03/2002
2	Neoadjuvant Therapy 06/2004 - 03/2002
1	Brachytherapy 03/2021
1	Adjuvant Radiotherapy 03/2021
1	Gynecologic Surgical Procedures (Gynecologic Surgery) 01/2019
1	Adjuvant Chemotherapy 02/2018
1	Trachelectomy 04/2017
1	Combination Drug Therapy (Combination Chemotherapy) 01/2017
1	Laparotomy 06/2014